nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—PTGFR—GPCRs, Other—GNRHR—adrenal gland cancer	0.0805	0.0848	CbGpPWpGaD
Carboprost Tromethamine—Tafluprost—PTGS2—adrenal gland cancer	0.0508	1	CrCbGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0453	0.0477	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0443	0.0467	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0405	0.0426	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0396	0.0417	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.0326	0.0344	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.0319	0.0336	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.03	0.0316	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0293	0.0309	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0271	0.0286	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0265	0.028	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.0242	0.0255	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.0237	0.025	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0228	0.024	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0223	0.0235	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.018	0.0189	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0176	0.0185	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.016	0.0169	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0157	0.0165	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0137	0.0144	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0134	0.0141	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0129	0.0136	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0126	0.0133	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—TSHR—adrenal gland cancer	0.0122	0.0128	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—TSHR—adrenal gland cancer	0.0119	0.0126	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0117	0.0123	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0115	0.0121	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00773	0.00814	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00756	0.00797	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GNAS—adrenal gland cancer	0.00709	0.00747	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00702	0.00739	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00694	0.00731	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GNRHR—adrenal gland cancer	0.00692	0.00729	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00689	0.00725	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00687	0.00723	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00677	0.00713	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00674	0.0071	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00643	0.00678	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0063	0.00663	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00627	0.0066	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—TSHR—adrenal gland cancer	0.00625	0.00659	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00613	0.00646	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00612	0.00645	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00605	0.00637	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00592	0.00624	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00479	0.00504	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—POMC—adrenal gland cancer	0.00477	0.00503	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00468	0.00493	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—POMC—adrenal gland cancer	0.00467	0.00492	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00449	0.00473	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00439	0.00463	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00419	0.00442	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GNRH1—adrenal gland cancer	0.00414	0.00437	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.0041	0.00432	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00406	0.00427	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00401	0.00422	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00392	0.00413	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CDC42—adrenal gland cancer	0.00381	0.00401	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SPRY2—adrenal gland cancer	0.00379	0.00399	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00373	0.00393	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00371	0.00391	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TSHR—adrenal gland cancer	0.00369	0.00389	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GNAS—adrenal gland cancer	0.00364	0.00383	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TSHR—adrenal gland cancer	0.00362	0.00381	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00356	0.00375	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MEN1—adrenal gland cancer	0.00347	0.00366	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MEN1—adrenal gland cancer	0.0034	0.00358	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—POMC—adrenal gland cancer	0.0027	0.00284	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PRKACA—adrenal gland cancer	0.00265	0.00279	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00264	0.00278	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PRKACA—adrenal gland cancer	0.0026	0.00273	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—POMC—adrenal gland cancer	0.00245	0.00258	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—POMC—adrenal gland cancer	0.0024	0.00253	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CDC42—adrenal gland cancer	0.00225	0.00237	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CDC42—adrenal gland cancer	0.0022	0.00232	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF2—adrenal gland cancer	0.00217	0.00228	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GNAS—adrenal gland cancer	0.00215	0.00226	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF2—adrenal gland cancer	0.00212	0.00224	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GNAS—adrenal gland cancer	0.0021	0.00222	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF1R—adrenal gland cancer	0.0021	0.00221	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF1R—adrenal gland cancer	0.00205	0.00216	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TERT—adrenal gland cancer	0.0018	0.0019	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TERT—adrenal gland cancer	0.00177	0.00186	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—BAD—adrenal gland cancer	0.00157	0.00165	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—BAD—adrenal gland cancer	0.00154	0.00162	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—POMC—adrenal gland cancer	0.00145	0.00152	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—BRAF—adrenal gland cancer	0.00143	0.00151	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—POMC—adrenal gland cancer	0.00142	0.00149	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—BRAF—adrenal gland cancer	0.0014	0.00147	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—adrenal gland cancer	0.00138	0.00146	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—adrenal gland cancer	0.00136	0.00143	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00103	0.00109	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00101	0.00106	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EGFR—adrenal gland cancer	0.000818	0.000862	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EGFR—adrenal gland cancer	0.000801	0.000844	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TP53—adrenal gland cancer	0.000687	0.000724	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TP53—adrenal gland cancer	0.000672	0.000708	CbGpPWpGaD
